GRN and cancer: As STAT3 signaling plays a pivotal role in the regulation of the cancer stromal and immune cells of the tumor microenvironment (Yu et al., 2007), the possible use of progranulin ASO in the clinic should take into account issues related to the modulation of STAT3 in such cell compartments.